|
|
Home | Submit Press Release | Advertise | Submit Website
(CityRegions.Com, May 10, 2018 ) The global antidepressants market is estimated to grow to approximately USD 13.4 billion by 2020, at a CAGR of 1.8%. Depression affects an estimated 121 million people worldwide and the antidepressant drug market reached sales of almost USD 11 billion in 2014.This study provides the market analysis for the major drug classes used for the treatment of depression.
Global Antidepressants Market-Market Dynamics
The report details several factors driving and restraining the market, some of which are discussed below.
Ask for Sample Report@ http://orbisresearch.com/contacts/request-sample/220334
Drivers
An increasing number of people suffering from stress and increase in the awareness level of disease state and clinical needs are factors that drive the market.
Restraints
Poor efficacy and safety profiles, repeated drug failures in clinical trials, availability of generics and weak pipelines are the restraints faced by the market.
The market for antidepressants has been segmented based on the various classes of drugs that are generally used for the treatment of these psychiatric conditions. Various drug classes considered while estimating the overall market are selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tetracyclic antidepressants (TeCAs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), benzodiazepines, beta-blockers, atypical antipsychotics, and anticonvulsants. These drug classes cover major depressive disorder (MDD), obsessive-compulsive disorder (OCD), generalized anxiety disorder (GAD) and panic disorder (PD).
The report tells us about the symptoms, side effects and whether the drug is good for pregnant or breastfeeding women. The study says that biological differences, brain chemistry, hormones, inherited traits, etc. are the major causes of depression.
In terms of geography, the global antidepressants market has been categorized into four major regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). Canadians are among the world's biggest users of antidepressants, with as much as 9% of the population on one depression-fighting drug or another. Like other countries, the use of antidepressants in the US has soared. In 1998, 11.2 million Americans used these drugs. By 2014, it was 23.3 million. Despite this rise, expenditure on antidepressants has barely risen as the drugs have become cheaper – from USD 624 per person in 1998 to USD 651 in 2014.
Browse complete report with table of content and list of figures@ http://orbisresearch.com/reports/index/global-antidepressants-market-segmented-by-antidepressant-therapies-depressive-disorders-and-geography-2017-2022
Some of the key players in the market are:
AstraZeneca
Bristol-Myers Squibb Company
Eli Lilly and Company
Forest Laboratories
GlaxoSmithKline
Pfizer Inc.
What the Report Offers
Market definition for the global antidepressants market along with identification of key drivers and restraints for the market.
Market analysis for the antidepressant market, with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
Table of Content
1 Introduction
1.1 Report Desciption
1.2 Research Methodology
1.3. Stakeholders
2 Executive Summary
2.1 Key Findings
2.2 Market Overview
3 Market Overview
3.1Market Definition
3.2 Market Drivers
3.2.1 Increasing Surgical procedures
3.2.2 Increasing need for managing blood loss
3.2.3 Increasing use of Surgical Adhesives
3.2.4 Advancement in technology and its use
3.3 Pipeline - Products currently in development
3.3.1 By Companies
3.3.2 By Universities/institutions
3.4 Market Challenges
3.4.1 Regulatory requirements (Clinical Data)
3.5 Porter's five forces for cord blood stem cell market
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Competition
3.5.4 Threats of new entrants
3.5.5 Threats from substitutes
Continued
For discount click here@ http://orbisresearch.com/contacts/discount/220334
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
For More PR’s: http://orbisnewsrelease.com
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Orbis Research
Hector Costello
+1 (214) 884-6817
sales@orbisresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
